Gameto ^Competitor

Gameto is a biotechnology company focused on advancing women's health, particularly in reproductive health and fertility. Founded by physician Dina Radenkovic and entrepreneur Martin Varsavsky, Gameto aims to meet significant needs in this field through innovative technologies. The company has been recognized as a 2023 Technology Pioneer by the World Economic Forum for its impactful work.

One of Gameto's key programs is Fertilo, which allows for the maturation of eggs outside the body using induced pluripotent stem cells. This approach aims to streamline IVF and egg freezing processes, making them shorter and safer. Gameto has also developed an "ovary-in-a-dish" technology, which has received FDA approval for investigation, potentially improving the efficiency of egg maturation. Additionally, the company is working on cell therapies to address menopause-related issues and has a program targeting male factor infertility. Gameto has secured significant funding to support its initiatives and expand its offerings in reproductive health.